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1. Introduction 
Despite the genetic and environmental factors and the aging process itself, multiple 
evidence from experimental models and postmortem studies in Alzheimer’s disease (AD) 
brain tissue demonstrate that neurodegeneration is associated with morphological and 
biochemical features. Considerable evidence suggests a role for oxidative stress/damage 
(amyloid beta peptide, iron/hydrogen peroxide) or neurotoxic by-products of lipid 
peroxidation (4-hydroxy-2-nonenal, acrolein) and inflammation, in the pathogenesis of 
neuron degeneration, which, in turns, are known to cause cell death.  
Recently, several reports indicate that, among factors, metal ions (Al, Zn, Cu, Fe, etc) could 
specifically impair protein aggregation and their oligomeric toxicity. Also, metal-induced 
(direct) and metal-amyloid-β (indirect) linked neuronal cell death through the formation of 
reactive oxygen species (ROS) being critical to the understanding of the mechanisms which 
metal-induced cell death, and thus its role in neurodegenerative disorders. 
Some metals are essential for humans and for all forms of life. Even though metals are 
necessary in biological systems, they are usually required only in trace amounts; in excess, it 
can be toxic, if not fatal. Environmental metal exposure has been suggested to be a risk factor 
for AD. High-term exposure to certain metals like manganese (Mn), iron (Fe), aluminum (Al) 
and many others like copper (Cu), mercury (Hg), zinc (Zn), lead (Pb), arsenic (As), alone or in 
combination, can increase neurodegenerative process, especially to Alzheimer’s disease (AD).  
Aluminum is the most widely distributed metal in the environment and is extensively used 
in daily life that provides easy exposure to human beings. No biological function of the 
element has been identified, whereas some aspects of its toxicity have been described. It has 
been suggested that there might be a relationship between high levels of Al and increased 
risk of a number of pathogenic disorders, such as microcytic anemia, osteomalacia and, 
possibly, neurodegenerative disorders including dialysis encephalopathy, Parkinson’s 
disease and Alzheimer’s disease. 
This metal is known to be extremely neurotoxic and in high levels is capable to inhibit the 
prenatal and post-natal development of the brain. Evidence from clinical and animal studies 
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demonstrated that brain Al content increases with age and that Al generates reactive oxygen 
species (ROS) that activates signaling pathways which leads to degeneration of neuronal 
cells. Together with ROS or alone, Al is biochemically attracted to the DNA reveling its 
genotoxic and mutagenic potential. 
Furthermore, high level of Al has been found in brain lesions, such as plaques and tangles, 
in patients with AD. Several studies demonstrated that among others, Al appears to be the 
most efficient cation in promoting Aβ aggregation, increasing dramatically cellular 
neurotoxicity. According to the “amyloid cascade hypothesis”, accumulation of Aβ in the 
brain is the primary event driving AD pathogenesis, increasing the evidences by which Al is 
involved in AD. 
Iron is an essential trace element used by almost all living organisms, being often 
incorporated into the heme complex, which mediate redox reactions. Disturbances of brain 
iron homeostasis have been linked to acute neuronal injury. Moreover, iron is toxic to neural 
tissue, leading to neurodegenerative disorders. 
Organic iron (Fe) may increase the genotoxic effects of other compounds when they are 
combined. Together with aluminum sulfate, at nanomolar concentrations, iron trigger the 
release of reactive oxygen species (ROS). In high levels, iron can be mutagenic and 
genotoxic. In AD, iron is an important cause of oxidative stress because of its over-
accumulation in the brain and colocalizes with AD lesions, senile plaques and 
neurofibrillary tangles.  
Recent studies also show that homeostasis of essential metals such as copper, iron, selenium 
and zinc may be altered in the brain of subjects with Alzheimer's disease. It is demonstrated 
that the plasma concentrations of manganese and total mercury were significantly higher in 
subjects with AD than in controls, however the concentrations of vanadium, manganese, 
rubidium, antimony, cesium and lead were significantly lower among subjects with AD 
cerebrospinal fluid.  
The influence of metal ions such as Fe, Cu, and Zn in stimulating Aβ aggregation have been 
widely studied where they appears to vary depending on tissue pH. It should be noticed 
that, although there is co-localization of metal ions in the pathological markers of AD, this 
does not indicate a causative role for these elements in the pathogenesis of the disease. 
Independently of metals being a primary cause or consequence of the disease mechanism, a 
change in a single metal ion can cause a significant imbalance on homeostasis in elemental 
levels in the body (serum, CSF and brain) leading to as a sort of “domino effect”. It is clear 
the need to understand the fundamental biochemical mechanisms linking brain biometal 
metabolism, environmental metal exposure, genotoxicity and AD pathophysiology. In this 
review, we discuss the role of metals in Alzheimer disease and its involvement in 
genotoxicity.  
2. Source of metal exposure 
Metals have been used throughout human history to make several utensils, machines, 
jewelry, and so on, where many of then were obtained through mining and smelting, 
activities that increases their distribution throughout the environment. Furthermore, the use 
of metals in industry, medicine, agriculture have been increased over the years, which 
increase the exposure, not only for those workers involved directly in working with metals 
but also consumers of the products and the general public through environmental 
contamination (Ferrer, 2003; Ansari et al., 2004).  
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Metals are among the oldest toxic agents known by humans. Its history starts prior to 2000 
BC when it became available as a byproduct of silver smelting. The early Greeks and 
Romans documented both the toxic as well as the potential healing effects of metals. 
Theophrastus of Erebus (370-287 BC) and Pliny the Elder (23-79 AD) described the 
pernicious effects of arsenic and mercury on miners and smelters (Hollenberg, 2010). 
In an industrialized world, there are thousands of types of metals in use, and humans are 
exposed to them at work, or as a result of contamination of food, water and environment. 
There is abundant evidence indicating an increase of neurodegenerative disorders like AD 
in industrialized countries (Veldman et al., 1998; Butterworth, 2010). The chronic exposure 
to metals from several years together with the advance of medical tools may explain why 
the diagnosis of AD and so its epidemic starts around 1980. 
Aluminum is the most widely distributed metal in the environment and is extensively used 
in a wide variety of products: cans, foils and kitchen utensils, as well as parts of airplanes, 
rockets and other items that require a strong, light material. It can be deposited on the 
surface of glass to make mirrors, and also to make synthetic rubies and sapphires for lasers. 
Al is found in the environment in its natural forms or as a source of human contamination 
resulting from mining and smelting, activities that increase their distribution throughout the 
environment. Al occurs naturally only in compounds, never as a pure metal. Because of its 
strong affinity to oxygen, it is almost never found in the elemental state; instead it is found 
in oxides or silicates (WHO, 1997; Nayak, 2002).  
In nature, this trace element is found in its oxidized state Al3+ (soluble toxic form of Al), 
which binds to others molecules like chloride, forming Aluminum chloride (AlCl3) (Smith, 
1996; WHO, 1997). Aluminum chloride (AlCl3) is an important coagulant used in water 
treatment and purification (WHO, 1997; Zhang e Zhou, 2005) being another source for 
exposure. Two of the most common compounds are potassium aluminum sulfate 
(KAl(SO4)2·12H2O), and aluminum oxide (Al2O3).  
Although aluminum is a widespread element, almost all metallic aluminium is produced 
from the ore bauxite (AlOx(OH)3-2x). Bauxite is a complicated mixture of compounds 
consisting of 55% of aluminum, oxygen, and other elements (WHO, 1997; Nayak, 2002). 
Large reserves of bauxite are found in Australia, Brazil, Guinea, Jamaica, Russia, and the 
United States. 
No biological function of the element has been identified, whereas some aspects of its 
toxicity have been described (Berthon, 1996; Corain et al., 1996; Suwalsky et al., 2001). The 
exposure to this toxic metal occurs through air, food, water and it is also present in medical, 
cosmetic and environmental products (Berthon, 2002). 
Daily consumed of Al by food and beverages is 2.5 to 13 mg, where drinking water can 
contributes to 0.2 to 0.4 mg of Al daily. Drugs can contribute with increase levels of Al; 
antiacid drugs (2 tablets) can contribute up to 500 mg of Al (WHO, 1997). As the world 
becomes more industrialize, the chronic exposure to Al increases, increasing the risk for the 
development of neurodegenerative disorders like AD and PD. 
The period in human history beginning in about 1200 B.C. is called the Iron Age. Iron is a 
transition metal and normally does not occur as a free element (Meteoric origen) (O´Neil, 
1994). The most common ores of iron are hematite, or ferric oxide (Fe2 O3); limonite, or ferric 
oxide (Fe2 O3); magnetite, or iron oxide (Fe3 O4 ); and siderite, or iron carbonate (FeCO3). An 
increasingly important source of iron is taconite. Taconite is a mixture of hematite and silica 
(sand). The largest iron resources in the world are in China, Russia, Brazil, Canada, 
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Australia, and Índia. Furthermore, almost all rocks and soils contains at least trace amounts 
of iron (Sienko, 1977). 
Iron is a very reactive metal. Most of then are found as Fe2+  which are oxidize to Fe3+. 
Combines with oxygen in moist air and the product of this reaction is iron oxide (Fe2 O3) 
(Cox, 1995). Iron also reacts with very hot water and steam to produce hydrogen gas. It also 
dissolves in most acids and reacts with many other elements. All of this reaction can be a 
source for contamination. 
Iron is a silvery-white or grayish metal. It is ductile and malleable, very high tensile strength 
and workable. In general, iron products can be found in automotive, construction, 
containers, machinery and industrial equipment, railroad tracks, oil and gas industries, 
electrical tools, appliances and utensils (Ilo, 1997). Furthermore, the fastest growing use of 
iron compounds is in water treatment systems. 
Populations are exposed to iron mainly through foods and beverages. It is available in a 
number of foods, including meat, milk, eggs, nuts, coffee, tea, fish, grain, soil and raisins. 
Iron can also be found in fresh water, where recommended levels can not exceed 0.3 mg of 
iron in 1 liter of water (WHO, 1996). The United State Recommended Daily Allowance 
(USRDA) for iron is 18 milligrams, being the amount of iron that a person needs to stay 
healthy. Also, daily recommended doses of Fe varies among age; for children up to 3 
months, 1.7 mg/kg/daily are recommended, whereas for adults this is 10 times more (18 
mg/kg/daily)(WHO, 1996). 
An iron deficiency can cause serious health problems in humans. Also, several alterations 
have been related to high iron intake where iron is toxic to neural tissue, leading to 
neurodegenerative disorders like AD (Montgomery, 1995; Campbell & Bondy, 2000; 
Stankiewicz & Brass, 2009). 
Manganese is a transition metal and it took several years to discover the difference between 
manganese and iron, mainly because it oftens occurs together in the Earth's crust and its 
similarity properties.  
Manganese is a moderately active metal and never occurs as a pure element in nature. It 
always combines with oxygen in the air to form manganese dioxide (MnO2) or other 
elements. It also combines with fluorine and chloride to make manganese difluoride (MnF2) 
and manganese dichloride (MnCl2) (WHO, 1999). The most common ores of manganese are 
pyrolusite (MnO2), manganite, psilomelane, and rhodochrosite. Manganese is also found 
mixed with iron ores. The largest producers of manganese ore in the world are China, South 
Africa, the Ukraine, Brazil, Australia, Gabon, and Kazakstan.  
Early artists were familiar with pyrolusite and they used the mineral to give glass a 
beautiful purple color, and/or to remove color from a glass. By the middle 1700s, chemists 
proved that pyrolusite contained manganese dioxide. Until now, coloring agents (textiles, 
paints, inks, glass, and ceramics) still contains manganous chloride. 
The most common alloy of manganese is ferromanganese, containing about 48 percent 
manganese combined with iron and carbon, being the source for making a very large variety 
steel products, including tools, heavy-duty machinery, railroad tracks, bank vaults, 
construction components, and automotive parts. Also, manganous chloride (MnCl2), is an 
additive in animal food for cows, horses, goats, and other domestic animals. In agriculture, 
manganous chloride are present in fertilizers (Barceloux, 1999). 
Manganese is one of the chemical elements that has both positive and negative effects on 
living organisms because manganese is used by many enzymes in an organism. A very 
small amount of the element is needed to maintain good health. The absortion of Mn is only 
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3 to 5%, being food the primary source of this metal. Mn is found in green vegetables, nut, 
raisins, and also in teas, its main source for human consumption. Low concentrations are 
found in Milk, meat, fish, eggs and fruits (Barceloux, 1999). Taking all together, soil, 
fertilizer and food, one can say that humans are exposed to Mn and that excess of 
manganese can create health problems. Also, a variety of drugs and supplements have Mn 
in its composition  (WHO, 1999). 
Human exposure can be also by inhalation. Workers may inhale manganese dust in the air 
in a factory or mine. Also, human can be exposed by the ingestion of contaminated water 
with fertilizers and pesticides (WHO, 1999). Exposures to high levels of manganese by 
ingestion or inhalation can damage the central nervous system. Daily-recommended doses 
of Mn for children are 0.3 mg/Kg/daily, being 3 times more for adults (10 mg/Kg/daily) 
(WHO, 1999). 
3. Metal neurotoxicity 
Abnormal production or clearance of a small peptide, the amyloid β-peptide (Aβ), which is 
the major constituent of the senile plaques, is a widely accepted causative agent in 
degenerative disorders like AD (Hardy & Selkoe, 2002; LaFerla et al., 2007; Qiu & Folstein, 
2006; Rauk, 2009; Sayre et al., 1997; Selkoe, 2000). Aβ is a 39- to 43-residue peptide cleaved 
from the C-terminal region of a much larger protein, the amyloid precursor protein (APP), 
where the most abundant fragments are Aβ (1–40) and Aβ (1–42), being the latter the most 
neurotoxic (Rauk, 2009). 
Several studies have shown that Aβ exerts its toxicity by generating reactive oxidative stress 
(ROS) molecules, leading to peroxidation of membrane lipids and lipoproteins, induction of 
H2O2 and hydroxynonenal (HNE) in neurons, damages DNA and transport enzymes 
inactivation (Behl et al., 1994; Kontush et al., 2001; Mark et al., 1997; Mark et al., 1997; 
Varadarajan et al., 2000; Xu et al., 2001). In addition to a high metabolically levels of ROS, 
there are other sources that are thought to play an important role in the AD progression. 
Among them, mitochondrial and metal abnormalities are the major sources of oxidative 
stress (Su et al., 2008). 
Increasing evidences suggest that altered metal homeostasis may contribute to neuronal loss 
in neurodegenerative diseases (Gerlach et al., 2006; Sayre et al., 2005; Wright, 2008). Given a 
likely role for metal-associated oxidative stress, herein it is discuss the involvement of 
metals, such as Al(III), Fe(III) and Mg(II) in neurotoxicity. 
3.1 Aluminum and neurotoxicity 
Aluminum (Al) is the third most abundant element in the earth’s crust and is not an 
essential trace metal for mammals. However, the concentrations found in the body can be 
sufficient to modify the activity of several key enzymes and second messenger pathways 
(Bondy, 2010).  
Aluminum is known to be extremely neurotoxic and in high levels is capable to inhibit the 
prenatal and post-natal development of the brain (Yumoto et al., 2001). Several studies 
correlated the risk of developing Alzheimer’s disease with residing in areas where 
aluminum concentrations in the drinking water are 100 mg/L or greater (McLachlan et al., 
1996; Rondeau et al., 2000). 
The hypothesis that there is a link between aluminum and Alzheimer's disease (AD) was 
first brought out in the 1960s by Terry and Pena (1965) and by Klatzo and colaborators in 
www.intechopen.com
 Alzheimer’s Disease Pathogenesis-Core Concepts, Shifting Paradigms and Therapeutic Targets 
 
408 
1965 (Terry et al., 1969). Early on 1976, high levels of aluminum have been found in brain 
lesions, such as plaques and tangles, in patients with AD (Crapper et al., 1976), and also in 
other conditions such as Parkinson’s disease (PD), pre-senile dementia, amiotrofic lateral 
esclerosis, neurofibrilar degeneration, dialysis encephalopathy syndrome and nigroestriatal 
sindrome (Altschuler, 1999; Gupta et al., 2005; Nayak, 2002; Yasui et al., 1992; Zatta et al., 
1991). Elevated aluminum levels have also been reported in other less common neurological 
disorders such as the Guamanian Parkinsonian-ALS constellation and Hallervorden-Spatz 
disease (Eidelberg et al., 1987; Garruto et al., 1989). 
The most common neurostrutural alterations induced by high levels of aluminum in the 
brain is: brain ventricle dilatation and thinning of the corpus callosum (Lapresie et al., 1975), 
reduce neural cell density, degenerative changings like picnosis, vacuolization, chromatin 
condensation (Varner et al., 1998), increase neural filaments in neuron from the spinal cord 
and brainstem (Terry et al., 1969), axonal intumescence (Troncoso et al., 1985) and cerebellar 
disorder with degeneration of the Purkinje  cells (Ghetti et al., 1985; Yokel, 1994). 
There is some experimental evidence that Al exposure can adversely affect the 
dopaminergic system. Extended exposure to 100mM Al lactate increased striatal levels of 
the dopamine metabolite (Li et al., 2008), what, in turns, suggests that exposure to Al may 
cause increased turnover of dopamine. The development of an encephalopathy, 
characterized by cognitive deficits, in-coordination, tremor and spinocerebellar 
degeneration, among workers in the aluminum industry also indicates that exposure to the 
metal can be profoundly deleterious. Abnormal neurological symptoms have been observed 
in several patients receiving intramuscular injections of Al-containing vaccines. 
There have been many experimental studies on animals and on isolated cells showing that 
aluminum has toxic effects on the nervous system. In 1991, Guy and colaborators showed 
that the uptake of aluminum by human neuroblastoma cells display an epitope associated 
with Alzheimer's diseases. Chronic exposure of animals to aluminum is associated with 
behavioural, neuropathological and neurochemical changes. Among them, deficits of 
learning and behavioural functions are most evident (Kummar et al., 2009; Ribes et al., 2010; 
Sethi et al., 2008). Also, when mice were injected with adjuvants containing aluminum in 
amounts equivalent to those given to US military service personnel, neuroinflammation and 
cell loss were found in spinal cord and motor cortex, together with memorial deficits (Petrik 
et al., 2007). 
Several metals interact with β-amyloid (Aβ) in senile plaques. It is interesting to note that, 
compared to other Aβ-metal complexes (Aβ-Fe, Aβ-Zn, Aβ-Cu), Aβ-Al is unique in 
promoting a specific form of Aβ oligomerization that has marked neurotoxic effects (Drago 
et al., 2008). 
There are a lot of ways which Al can damage neural cells: (i) interfering with glucose 
metabolism, leading to low amounts of Acetilcholine (Ach) precursors; (ii) interacting to 
ATPase Na+/K+ and Ca2+/Mg2+ -depending, altering excitatory aminoacid release; (iii) 
inhibition the binding of Ca++; (iv) incresing the production of AMPc; (v) causing changes in 
the cytoskeleton protein, leading to phosphorilation, proteolysis, transport and synthesis 
disruption; (vi) interacting directly to genomic structures, and most importantly (vii)  
inducing oxidative damage by lipid peroxidation (Nayak & Chatterjee, 1999).  
Being involved in the production of reactive oxygen species (ROS), aluminum may cause 
impairments in mitochondrial bioenergetics and may lead to the generation of oxidative 
stress which may lead to a gradual accumulation of oxidatively modified cellular proteins, 
lipids and affects endogenous antioxidant enzyme activity, leading to degeneration of 
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neuronal cells (Kummar et al., 2009; Sethi et al., 2008; Wu et al., 2010). In this way, 
aluminum is a strong candidate for consideration as a subtle promoter of events typically 
associated with brain aging and neurodegenerative disorders. 
3.2 Iron and neurotoxicity 
Metal ion homeostasis is maintained through highly regulated mechanisms of uptake, 
storage, and secretion (Mills et al., 2010). Iron plays a role in oxygen transportation, myelin 
synthesis, neurotransmitter production, and electron transfers, being a crucial cofactor in 
normal central nervous (CNS) metabolism. Iron is also abundantly in substantia nigra and 
globus palladium when compared with other regions and is found to increase with age in 
humans (Bartzokis et al., 1994; Lee et al., 2010; Zecca et al., 2001). Normally, under healthy 
conditions, these metal ions are bound to ligands (e.g., transferrin), however when they are 
found nonbound, iron are potentially harmful mainly due to their redox activities in the 
synaptic cleft (Salvador et al., 2011).  
Free iron catalyzes the conversion of superoxide and hydrogen peroxide into hydroxyl 
radicals, which promote oxidative stress by the Fenton reaction (Berg et al., 2001). 
Furthermore, ROS interacts with a variety of molecules, including unsaturated fatty acids, 
proteins and DNA leading to subsequent cell death/apoptosis, especially on CNS tissue, 
whereas the antioxidant defenses are rare (Demougeot et al., 2003; Stankiewicz & Brass, 
2009; Willmore & Rubin, 1984). Thus, disturbances of brain iron homeostasis have been 
linked to acute neuronal injury leading to neurodegenerative disorders (Campbell & Bondy, 
2000; Montgomery, 1995) such as Alzheimer’s (AD), Parkinson’s (PD), and Huntington’s 
(HD) diseases as well as amyotrophic lateral sclerosis (ALS) (Connor & Benkovic, 1992; Kell, 
2010; Liu et al., 2006; Rouault, 2001; Youdim  et al., 2005).  
Degradation of the dopaminergic system, where catechols molecules should be produced, 
may play a role in the extrapyramidal symptoms in PD (Prikhojan et al, 2002; Santiago et al., 
2000). In vitro studies have shown that iron is accumulated in microglia and astrocytes in the 
cerebral cortex, cerebellum, substantia nigra, and hippocampus, and it is believed that this 
metal would be involved in the neuroinflammation observed in AD and PD (Ong & 
Farooqui, 2005). 
Postmortem studies in PD subjects, suggests that accumulation of iron in the substantia 
nigra stimulates lipid peroxidation, which can lead to cell damage (Nakano, 1993; Riederer 
et al., 1989).  Studies conducted with PD subjects demonstrated that in mild PD, there were 
no significant differences in the content of total iron between the PD group and control, 
whereas there was an increase in total iron and iron (III) in substantia nigra of severely 
affected patients (Riederer et al., 1989). Indeed, lateral substantia nigra pars compacta 
abnormalities were observed in early PD together with increased iron content.  
Within the reduction on glutathione and the change of the iron (II)/iron (III) ratio in favor of 
iron (III), it is suggest that these changes might contribute to pathophysiological processes 
underlying PD (Griffiths et al., 1999; Lan & Jiang, 1997; Martin & Wiler, 2008). Interestingly, 
the increase in iron in the degenerating substantia nigra (SN) occurs only in the advanced 
stages of the disease, suggesting that these phenomena may be a secondary event, rather 
than a primary (Double et al., 2000). Patients with diagnosed AD and in normal elderly 
patients, iron concentrations have been found to be increased in the bilateral hippocampus, 
parietal cortex, frontal white matter, putamen, caudate nucleus, thalamus, red nucleus, 
substantia nigra, and dentate nucleus subregions. Particularly in the parietal cortex, at the 
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early stages of AD, studies have been found to positively correlate with the severity of 
patients’ cognitive impairment (Sullivan et al., 2009; Zhu et al., 2009). 
Although extensive evidence links the iron metabolism, aging, and neurodegenerative 
disorders, relatively little is known about the resulting forms of iron that accumulate in the 
brain. Numerous techniques have been developed in order to characterize, locate, and 
quantify iron species and iron- containing compounds in the brain, however, more studies 
are needed to understand the role of this transition metal in the onset and progression of 
neurodegenerative diseases and neurological age-related disorders. 
3.3 Manganese and neurotoxicity 
Manganese is an essential element for many living organisms, especially humans, where 
some enzymes require (e.g., manganese superoxide dismutase), and some are activated, by 
manganese (Hurley & Keen, 1987). Excess accumulation of these metal by ingestion or 
inhalation (mostly in working place) (Agency for Toxic Substances and Disease Registry 
[ATSDR], 2000) can damage the central nervous system (Winder et al., 2010) most likely due 
to impaired transport or failure of hepatic detoxification mechanisms, what have deleterious 
effects on cell function and integrity (Butterworth, 2010).  
It is known that astrocytes have a much higher affinity and capacity for manganese uptake 
compared to neurons and that exposure to manganese results primarily in alterations of 
astrocyte morphology and function (Aschner et al., 1992). Excessive exposure to Mn can also 
lead to neural lesion, primarily on the dopaminergic pathway (globus pallidus and 
substantia nigra pars reticulata), inhibiting dopamine metabolism (Vidal et al., 2005).  
Short-term repeated pulmonary exposure to manual metal arc-hard surfacing or gas metal 
arc-mild steel fumes resulted in selective deposition of Mn in the brain, particularly in 
dopaminergic brain areas. It is interesting to note that, other constituents of the fumes like 
Fe, Cr, Ni or Cu did not appear to translocate to the brain despite their large accumulation 
in the lungs and its associated lymph nodes. Molecular markers of dopaminergic 
neurotoxicity and injury response can be found in the brain of welding fumes, extended 
beyond the globus pallidus, considered the primary site of damage in manganism, to 
broader dopaminergic areas (Sriram et al., 2010). 
Neurotoxic effect of Mn can be due to its interaction with detoxification enzymes that 
protects the cells, and/or its interaction with the redox system. In this way, Mn2+ (necessary 
in the brain) can be oxidize to Mn3+, a toxic compound that enhances the oxidation of 
dopamine leading to a lots of neurotoxic products (Donaldson et al., 1982). Recent studies 
reveal that repeated exposure to Mn or Mn-containing welding fumes can cause 
mitochondrial dysfunction and alterations in the expression of proteins in dopaminergic 
brain areas, also, events that contribute to dopaminergic neurotoxicity (Sriram et al., 2010). 
Some evidences indicate that the neurological abnormalities can be found on the striatum 
and on subthalamic nucleus in the CNS of the monkey receiving MnCl2 by inhalation 
(Newland et al., 1999). Also, undesirable neurological effects were observed in children who 
were exposed to excess manganese (Zheng et al., 1998), what can explain the enhanced 
incidence of neurological symptoms in isolated populations (Florence & Stauber, 1989; 
Iwami et al., 1994). 
Adverse health effects can be caused by inadequate intake or overexposure to manganese. 
Chronic exposure to high levels of Mn induces a syndrome known as “manganism”, 
characterized by extrapyramidal dysfunction (bradykinesia, rigidity and dystonia) and 
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neuropsychiatric symptoms that resemble idiopathic Parkinson’s disease (Santamaria & 
Sulsky, 2010).  
Although is not completely clear the relationship between Mn and PD patogenesis, or 
neurodegenerative disorders, it is suggest that this metal accelerates neuronal death and 
increase the risk of its development (Zheng et al., 1998).  
4. Metal contamination and AD developing 
Metal are essential for humans and for all forms of life. Even though metals are necessary in 
biological systems, they are usually required only in trace amounts. As regard to the brain, 
metals are essential for neuronal activities. However, if not correctly regulated, redox-active 
can react with molecular oxygen to generate ROS thus causing brain lipid peroxidation and 
protein oxidation (Salvador et al., 2011; Sayre et al., 1997; Smith et al., 1996; Smith et al., 
1997).  Also, metal imbalance can lead to aberrant interactions between metals and AD-
related proteins, being a potential source of oxidative stress, which is evolved into the 
‘‘metal hypothesis’’ of AD (Iqbal et al., 2005).  
Protein misfolding associated with Aβ aggregation, is significantly affected by various 
biological, biophysical and chemical factors including metal ions such as Al, Cu, Zn, and Fe, 
which have been found in high concentration in the AD brain (Beauchemin et al., 1998; 
Dong et al., 2003; Lovell et al., 1993; 1998; Miu et al., 2006; Suh et al., 2000;). Also, some 
metals are able to accelerate the dynamic of Aβ aggregation, thus increasing the neurotoxic 
effects on neuronal cells (Bush, 2003; House et al., 2004; Maynard et al., 2005; Miu et al., 
2006; Morgan et al., 2002; Ricchelli et al., 2005). Kawahara et al. (2001) showed that 
aluminum induces neuronal apoptosis in vivo as well as in vitro and causes the 
accumulation of hyperphosphorylated tau protein and Aβ protein in in vivo model. 
Several studies have focused on the role of metal ions including Al on the Aβ aggregation 
properties (House et al., 2004; Kawahara et al., 1994; Pratico et al., 2002; Ricchelli et al., 2005), 
suggesting that, among various metal ions assessed, Al seems to be the most efficient in 
promoting Aβ aggregation in vitro, increasing cellular neurotoxicity (Kawahara et al., 2001; 
Kawahara, 2005; Ricchelli et al., 2005). Also, Al induces the spontaneous increase of Aβ1-42 
surface hydrophobicity compared to Aβ alone, which in turns, the complex Aβ1-42-Al 
reduced the capillary sequestration increasing its permeability through the blood brain 
barrier resulting intracerebral accumulation as demonstrated by Banks et al. (2006). 
Environmental metal exposure has been suggested to be a risk factor for AD. High-term 
exposure to certain metals like manganese (Mn), iron (Fe), aluminum (Al) and many others, 
alone or in combination, can increase neurodegenerative process, especially to Alzheimer’s 
disease (AD).  
Aluminum (Al) is the most abundant neurotoxic metal on earth, widely bioavailable to 
humans and repeatedly shown to accumulate in AD-susceptible neuronal foci. Furthermore, 
several groups reported an increased amounts of Al in neurofibrillary tangles (NFT)- 
bearing neurons of AD brains, suggesting the association of Al with NFTs (Good et al., 1992; 
Lovell et al., 1993). Evidence from clinical and animal model studies demonstrated that 
brain Al content increases with age, suggesting an increased exposure or a decreased ability 
to remove Al from brain with age (Savory et al., 1999). Furthermore, high levels of Al has 
been found in brain lesions, such as plaques and tangles, in patients with AD and could be 
involved in the aggregation of Aβ peptides to form toxic fibrils (Sakae et al., 2009).  
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Iron is an essential trace element used by almost all living organisms. However, 
disturbances of brain iron homeostasis have been linked to acute neuronal injury. Increased 
iron levels were found both in the cortex and cerebellum from the preclinical AD cases 
(Sullivan et al., 2009; Zhu et al., 2009). Cellular studies have shown that iron is particular 
accumulated in microglia and astrocytes in the cerebral cortex, cerebellum, substantia nigra, 
and hippocampus, and it is believed that this metal would be involved in the 
neuroinflammation found in AD and PD (Ong & Farooqui, 2005; Sullivan et al., 2009; Zhu et 
al., 2009). It is important to note that these brain iron concentrations, especially in the 
parietal cortex at the early stages of AD, have been found to positively correlate with the 
severity of patients’ cognitive impairment (Zhu et al., 2009). Interestingly, Aβ insoluble 
aggregates have been demonstrated to be dissolved by metal chelators (Cherny et al., 1999). 
Iron itself has been related neurotoxicity, and its accumulation, has been observed to before 
AD lesions are measurable. In AD, iron is an important cause of oxidative stress because of 
its over-accumulation in the brain and colocalizes with AD lesions, senile plaques and 
neurofibrillary tangles. Interestingly, iron has been involved in lipid and protein oxidation 
and also in DNA damage. Iron is able to oxidize DNA bases, and it has been suggested that 
the accumulation of this transition metal in some neurodegenerative disorders could act by 
both increasing oxidative genome damage and also preventing its repair (Hegde et al., 
2010). 
Manganese (Mn) is an essential element for humans, animals, and plants and is required for 
growth, development, and maintenance of health, although it has been recognized as a 
neurotoxic metal for over 150 years (Weiss, 2010). Unbalance of Mn homeostasis has show 
cognitive deficiencies features that include diminished attention, reduced scores on tests of 
working memory, lower scores on intelligence tests, impaired learning, and slowed 
response speed. Also, Weiss (2010) reports that signs of Mn poisoning are impaired 
coordination, abnormal gait, abnormal laughter, expressionless face, weakness, 
bradykinesia, somnolence, dysarthria, difficulty walking, clumsiness, lack of balance, 
muscle pains, and diminished leg power.  Furthermore, exposure to high levels of inhaled 
manganese, as in miners working leads to motor symptoms.  
Nonhuman primates can be the most appropriate animal models for studies of manganese 
neurotoxicity because of their similarities to humans in brain anatomy and neurobehavioral 
function (Schneider et al., 2009). A recent study by Schneider et al. (2009) demonstrated that 
trained Cynomologous monkeys for memory test followed by a regimen of intravenous 
manganese sulfate injections over a period of about 230 days, displayed mild deficits in 
spatial memory, greater deficits in nonspatial memory, and no deficits in reference memory 
on animals treated. By analyzing Mn concentrations, the study showed a significant inverse 
relationship between working memory task performance and Mn levels. 
The relationship by Mn exposure and Alzheimer’s disease has also been investigated by 
gene array analysis of frontal cortex from Cynomologous monkeys after Schneider et al. 
(2009) studies (Guilarte et al., 2010). Amyloid-β Precursor-like Protein 1 (APLP1), a member 
of the Amyloid Precursor Protein (APP) family was the most expressed out of the 61 
upregulated genes. Along with this finding, immunochemistry revealed the presence of 
Amyloid-β plaques in the brain of subjects with only 6–8 years of age. Thus, these findings 
links the Mn-induced β-amyloid deposits to impaired memory function what may be 
extrapolated to human brain and so the features of AD pathogenesis. 
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5. Metal genotoxicity 
Cellular stresses, including DNA damage, have been linked to cell cycle deregulation in 
neurons (Park et al., 1998; Kruman et al., 2004). Studies on the biological causes of neuronal 
death in AD have been guided by observations of cell cycle reentry in cellular populations 
that degenerate in human disease (Busser et al., 1998; Yang et al., 2003). In addition to 
ectopic cell cycling, AD is also linked to DNA damage; accumulation of DNA damage in 
neurons is associated with aging (Lu et al., 2004) and is exacerbated in neurodegenerative 
disorders including AD (Rass et al., 2007). The occurrance of DNA damage was related in 
astrocytes of AD hippocampus (Myung et al., 2008) and in neurons within the cerebellar 
dentate nucleus that show the robust DNA damage response (Chen et al., 2010). 
The appearance of DNA damage during the course of lateonset neurodegenerative disease 
has been attributed in part to the fact that neurons exhibit high mitochondrial respiration, 
which is known to lead to the production of reactive oxygen-species. Over time this 
oxidative stress results in the accumulated damage of mitochondrial and nuclear DNA (Rass 
et al., 2007). These findings emphasize the value of using direct markers of neuronal 
distress, like DNA damage, as neuropathological markers in AD. They augment the classical 
histopathological picture achieved by staining for amyloid plaques and tau inclusions by 
providing an early neuronal vulnerability marker (Chen et al., 2010). 
As a consequence of industrial production, a large quantity of toxic material is released in 
the ambient. Due to the elevated concentrations of metals present in different environments, 
metals are ubiquitous contaminants of ecosystems; therefore, they are among the most 
intensely studied contaminants. They do not only deteriorate the physicochemical 
equilibrium of the ecosystems, but they also disrupt the food web and bring about 
morphological, physiological and cytogenetic changes in the inhabitants (Boge & Roche, 
1996). Genotoxic studies have shown that exposure to some metals causes adverse effects to 
different organisms, especially to humans, and these DNA damages may be implicated in 
the pathogenesis of some types of cancer and neurodegenerative diseases. 
5.1 Genotoxicity of aluminum 
Metal-induced genotoxicity is an important pathogenic mechanism whereby toxic metals 
that riches the nucleus affect the normal structure and function of the genome (Alexandrov 
et al., 2005; Lukiw, 2001; Sarkander et al., 1983).  
There are only few studies in the literature about the genotoxic activities of Al, both in vitro 
and in vivo. Aluminum is biochemically attracted to interact to the phosphates that form an 
active part of the DNA. Its mutagenic potential has been studied by micronucleus assay, 
sister chromatid exchange, Ames and chromosomal aberration analysis, showing a 
significant genotoxicity in vitro (Banasik et al., 2005; Lankoff et al., 2006).  Also, in vivo 
studies revealed that aluminum could induce in a dose-dependent manner an increase 
chromosomal aberrations (Roy et al., 1991). 
In vitro chromosomal aberrations induction, mostly numeric (anaphasic), was shown first 
by Moreno et al., (1997), in the Balb c 3T3 cell line exposed to atmospheric dust (20–80 
mg/mL), a mixture of particles of potassium aluminum silicates (98%) and sodium dioxide 
(2%), from Mexicali, Mexico. Other studies (Dovgaliuk et al., 2001a, 2001b) also 
demonstrated the cytogenetic effects of toxic metal salts including aluminum (Al[NO3]3) in 
meristematic cells from Allium cepa and the clastogenic and aneugenic effects (disturbances 
in mitosis and cytokinesis) in these cells. 
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More recently, the genotoxic potencial of AlCl3 on Vicia faba was investigated using 
cytogenetic tests, demonstrating that aluminum causes significant increase in the 
frequencies of micronuclei and anaphase chromosome aberrations in the root cells of Vicia 
faba (Yi et al., 2009). 
Iron and aluminum-sulfate together, at nanomolar concentrations, trigger the release of 
reactive oxygen species (ROS) in cultures of human brain cells, up-regulating pro-
inflammatory and pro-apoptotic genes that redirect cellular fate toward cytoplasmic 
dysfunction, nuclear DNA fragmentation and cell death (Alexandrov et al., 2005; Lukiw, 
2001; Sarkander et al., 1983). 
On neural cells from Parkinson´s disease patients, Al treatment did not increase the 
micronucleus frequency, indicating that Al had no amplified mutagenic effect on these 
patients (Trippi et al., 2001). Also, chromosome breaks were observed in V79-4 Chinese 
hamster cells irradiated with low-energy aluminum ions (Botchway et al., 1997). 
Furthermore, no teratogenic effects on the mouse fetus or genotoxic effects as detected by 
the Ames assay was observed for aluminum-containing cosmetic formulations (Elmore, 
2003).  
Lukim & Pogue (2007) first described the neurotoxic effects of aluminum-sulfate and 
aluminum- plus iron-sulfate on miRNA expression patterns in untransformed human brain 
cells in primary co-cultures of neurons and glia.  Low doses of aluminum have been found 
to disturb RNA Pol II-directed gene transcription in isolated human brain cell nuclei 
(Alexandrov et al., 2005; Lukiw, 2001) suggesting an involvement of soluble aluminum- and 
iron-sulfate in several different aspects of human brain gene expression, specially associated 
with transcriptional and post-transcriptional control. Synapsin mRNA has been found to be 
down-regulated in both AD brain and in iron- plus aluminum-sulfate treated primary cell 
culture (Alexandrov et al., 2005; Lukiw, 2007; Yumei et al., 1998). 
On the other hand, studies have demonstrated the mutagenic potential of Al in human cells. 
For example, genotoxicity of the dust derived from an electrolytic Al plant was evaluated 
using the Ames assay, unscheduled DNA synthesis test, sister chromatid exchange and 
micronuclei frequencies in human lymphocytes. The results of these four experiments 
indicated a high genotoxicity potential of the dust organic extract (Varella et al., 2007). The 
mutagenic activity of waste material originating from an Al products factory was 
determined by the Salmonella/microsome assay, where all extracts from the factory had 
mutagenic activity, especially in the YG1024 yeast strain, suggesting the presence of 
aromatic amines (WHO, 1997).  
Scalon et al (2011) assessed the genotoxic effects in fish exposed to samples from the Sinos 
River (Rio Grande do Sul – Brazil), and evaluated DNA damage from aluminum, lead, 
chromium, copper, nickel, iron and zinc contamination. They collected samples of different 
sites and on differente seasons in the Sinos River, and chemical analysis of the water showed 
presence of Al and Fe, exceeding the accepted limits in most of the water samples. The index 
of DNA damage assessed by the comet assay in the peripheral blood of a native fish species 
demonstrated no significant differences in different seasons or at the different sampling 
sites. Only the frequency of cells with higher level of DNA damage showed significant 
difference in comparison to the sampling period. However, the increase in that parameter of 
genotoxicity does not seem to be related to differences between sampling periods regarding 
the presence or concentration of the heavy metals analysed. 
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Garcia-Medina et al (2011) evaluated de genotoxic and cytotoxic effects of Aluminum 
sulphate on common carp (Cyprinus carpio). They exposed the fishes to 0.05, 120, and 239 
mg/L Alや (SOゆ)ゅ7HやO and analysed the cells with the comet assay, flow cytometry, and 
the TUNEL method. The analyzed cells showed significant increase in the amount of DNA, 
damage, DNA content increase and ploidy modifications, as well as apoptosis and 
disturbances of the cell cycle progression and an increase in the amount of apoptotic cells. 
These results suggests, in a contrary way to the study of Scalon et al (2011), that Al caused 
deleterious DNA and cellular effects in aquatic organisms. 
Recently our research group published a study on the genotoxic, clastogenic and cytotoxic 
effects of AlCl3 in different phases of the cell cycle using in vitro temporary cultures of 
human lymphocytes (Lima et al., 2007). Moreover, the mitotic index (MI), chromosomal 
aberrations (CAs) and DNA damage index were analyzed by the comet assay. The study 
indicated that AlCl3 induces DNA damage and is cytotoxic during all phases of the cell 
cycle. Also, the treatment of the cells at G1 phase resulted in polyploidy and 
endoreduplication, consistent with AlCl3 interacting with the mitotic spindle apparatus 
(Lima et al., 2007). These data, along with the results of other studies reported in the 
literature, indicates that AlCl3 is genotoxic and should be used with caution. 
More research is needed on this topic, since the use of aluminum cookware, aluminum-
containing deodorants and other products are increasing in general population. Moreover, 
environmental metal contamination contributes with the increase levels of metal exposure 
(Ansari et al., 2004). 
5.2 Genotoxicity of iron 
Several studies have been conducted to demonstrate the potential induction of DNA 
aberrations by iron (Fe) and also by drugs and compounds containing this metal.  However, 
the results are inconclusive, and its toxicity and mutagenic effect is still incompletely 
understood. 
Organic Fe may increase the genotoxic effects of other compounds when they are combined 
(WHO, 1998). For example, the mutagenic activity by doxorubicin is significantly increased 
within this metal, as evaluated by the Ames test (Kostoryz & Yourtee, 2001). Furthermore, 
Jurkat cells simultaneously treated with hydrogen peroxide and desferrioxamine (Fe 
chelator) significantly inhibit DNA damage, indicating that intracellular Fe, which is a 
redoxactive metal, plays a role in the induction of DNA strand breaks induced by hydrogen 
peroxide (Barbouti et al., 2001). 
High levels of chromosome and chromatid aberrations were found in human lymphocytes 
and TK6 lymphoblast cells exposed to high-energy iron ions (56Fe) (Durante et al., 2002; 
Evans et al., 2001, 2003). Significant DNA damage was detected, by microgel 
electrophoresis, in differentiated human colon tumor cells (HT29 clone 19A) treated with 
ferric-nitrilotriacetate (Fe-NTA) (Glei et al., 2002). Mutagenic activity was also found in 
elemental and salt forms of Fe, evaluated by mutagenicity tests in Salmonella typhimurium 
and L5178Y mouse lymphoma cells (Dunkel et al., 1999).  
Iron compounds have also been reported to be mutagenic in mammalian cells, as detected 
by the Syrian hamster embryo cell transformation/viral enhancement assay (Heidelberger et 
al., 1983), sister chromatid exchange (SCE) in hamster cells (Tucker et al., 1993) and base 
tautomerization in rat hepatocyte cultures (Abalea et al., 1999). 
Few or no DNA damage (detected by the comet assay) occurred after treatment of human 
lymphocytes with ferric chloride (FeCl3) and ferrous chloride (FeCl2), all of them known to 
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be iron compounds (Anderson et al., 2000a, 2000b). Also, low concentrations of either Fe2+ 
or Fe3+ were not mutagenic in Chinese hamster ovary cells (CHO-9) treated in vitro, and the 
mitotic index was also unaffected when compared to negative control. In the other hand, 
high concentrations of ferrous sulfate, induces significant DNA damage, probably as a 
consequence of chemical contamination of the metal salt (Antunes et al., 2005).  
Mutagenic potential of metallic agents used in dietary supplementation, including iron 
sulfate, was also investigated by means of the comet assay. The authors reported a genotoxic 
effect of this metal in mouse blood cells after 24 h of treatment, at all tested concentrations 
(Franke et al., 2006). Genotoxic effects of Fe were also reported by Garry et al. (2003) in rats 
treated with iron oxide (Fe2O5) for 24 h. They observed that this metal only showed 
mutagenic potential when the animals were simultaneously treated with benzopyrene.  
Furthermore, Hasan et al. (2005) reported that ferritin, an ubiquitously distributed iron 
storage protein, interacts with microtubules in vitro. In a study conducted by Maenosono et 
al. (2007) the bacterial reverse mutation assay using S. typhimurium was weakly positive for 
water-soluble FePt nanoparticles capped with tetramethylammonium hydroxide. Mice 
subchronically exposed to 33.2 mg/Kg Fe displayed genotoxic effects in whole blood in the 
alkaline version of the comet assay, with a significant increase in the hepatic level of Fe (Prá 
et al., 2008). 
High-energy iron ions (LET=151 keV/microM) could induce chromosomal aberrations 
(measured using the fluorescence whole-chromosome painting technique) in normal and 
repair-deficient human fibroblasts cell lines (George et al., 2009). 
Park & Park (2011) screened the potential toxicity of various iron-overloads on human 
leukocytes using comet assay. Ferric-nitrilotriacetate (Fe-NTA), FeSO(4), hemoglobin and 
myoglobin were not cytotoxic in the range of 10-1000 microM by trypan blue exclusion 
assay. The exposure of leukocytes to Fe-NTA (500 and 1000 microM), FeSO4 (250-1000 
microM), hemoglobin (10 microM) and myoglobin (250 microM) for 30 min induced 
significant DNA damage. Iron-overloads generated DNA strand break were rejoined from 
the first 1h, but no genotoxic effect was observed at 24h.  
Recently, our research group conducted an in vitro study aiming to investigate the 
genotoxic, clastogenic and cytotoxic effects of FeSO4 in different phases of the cell cycle, 
using short-term cultures of human lymphocytes. The bioactivity parameters tested were 
the mitotic index, chromosomal aberrations and DNA damage index as detected by the 
comet assay. Our results showed that Fe induces alterations and inhibition of DNA 
synthesis, which together explains the concomitant occurrence of mutagenicity and 
cytotoxicity (Lima et al., 2008). 
5.3 Genotoxicity of manganese 
Manganese displays an interestingly behavior with regard to its toxicity, since it is relatively 
non-toxic to the adult organism with an exception to the brain. Even at moderate amounts in 
a long period of time, when inhaleted can causes Parkinson-like symptoms. Those findings 
were also observed in animal studies which repeated intravenous Mn administration to 
monkeys (Olanow et al., 1996) produced a Parkinson-like syndrome characterized by 
bradykinesia, rigidity, and facial grimacing.  
The association of Mn with the risk of developing neurodegenerative processes can be 
related to DNA damage. Relatively high doses of Mn can disrupt DNA integrity and DNA 
replication (Beckman et al., 1985; De Meo et al., 1991; Van de Sande et al., 1982) and causes 
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mutations in microorganism (Orgel & Orgel 1965; Rossman et al., 1984; Rossman & Molina, 
1986) and mammalian cells although the Ames test does not appear to be particularly 
responsive to manganese or no suitable to detect toxicity of metal salts (Léonard, 1988).  
There are few studies in the literature on the genotoxic action of Mn. Its toxic potential has 
been studied by in vitro tests in bacteria and by in vivo/in vitro tests in insect and 
mammalian cells, showing that some chemical forms of this metal have mutagenic potential. 
Gerber et al. (2002) demonstrated that high doses (0.05 M) of various Mn compounds could 
affect DNA replication and repair in bacteria. As for mammalian cells, high doses of Mn 
(compared to the Mn doses recommended for daily consumption) can affect fertilization and 
are toxic to the embryo and fetus, demonstrating the teratogenic potential of this metal.  
Dutta et al. (2006) suggests the manganese dioxide as an established genotoxicant and 
clastogenic metal that can induce DNA strand breaks, chromosomal aberration and 
micronucleus in human peripheral lymphocytes. Manganese chloride (MnCl2) was also 
subjected to the wing spot test of Drosophila melanogaster and was shown to be clearly 
effective in inducing spots with one or two mutant hairs (small spots) at concentrations over 
12 µM (Ogawa et al., 1994).  
Concentrations of manganese in the general environment and manufacture products vary 
widely. Brega et al. (1998) demonstrated that farm workers exposed to pesticides containing 
Mn, even at a low levels, revealed an increased in the mutagenic potential of those 
pesticides, as evidenced by an increased number of CAs. It is possible that, at low doses, Mn 
has genotoxic effects only with long-term exposure, and this may be the reason why 
Timchenko et al. (1991) did not find CAs in the nasal mucosa of mammals exposed to Mn 
dioxide aerosol (40–12,000 Hz, 80–100 dB). Furthermore, it is possible that chronic exposure 
to low doses of Mn can induces CAs over the years.  
Studies on eukaryotic cell, revealed that manganese sulfate (MnSO4) did not display 
mutagenic potential in different strains of Salmonella typhimurium, while, manganese 
chloride, showed mutagenicity in the TA1537 strain of S. typhimurium as well as in the T7 
strain of Saccharomyces cerevisiae (doses over 0.5 mM) (WHO, 1999). In vivo studies have 
demonstrated that oral doses of manganese sulfate or potassium permanganate (KMnO4) 
induce CAs in the bone marrow of animals, whereas no CAs have been seemed after oral 
doses of manganese chloride, even at concentrations over 12 µM (WHO, 1999). These results 
show that the mutagenic potential of compounds of Mn may be different in permanganate 
salts and in manganese salts, depending on its chemical formulation, and thus being able to 
altering their biological availability, activity, and consequently, their toxicity. 
De Meo et al. (1991) evaluated the genotoxicity of potassium permanganate (KMnO4), 
manganese sulfate and manganese chloride using the Ames test within TA97, TA98, TA100 
and TA102 strains, with and without metabolic activation. The presence of direct-acting 
mutagens was detected in all Mn samples in TA102 strain without metabolic activation. 
Only manganese chloride induced DNA damage in human lymphocytes with a dose-
dependent response, as determined by the comet assay.  
Animal studies, demonstrated that acute lethality of manganese appears to vary depending 
on the chemical species. The central nervous system is the chief target of manganese toxicity. 
Oral doses produced a number of neurological effects in rats and mice, mainly involving 
alterations in neurotransmitter and enzyme levels in the brain (ATSDR, 2000; Deskin et al., 
1980), which can be accompanied to changes in activity level (ATSDR, 2000). Chronic 
ingestion of manganese (1–2 mg/kg/day) changes appetite and reduces haemoglobin 
synthesis in different animals (Hurley & Keen, 1987).  
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Long-term exposure to manganese can cause transient effects on biogenic amine levels and 
activities of dopamine β-hydroxylase and monoamine oxidase in rat brain (Eriksson et al., 
1987; Lai et al., 1984; Nachtman et al., 1986; Subhash & Padmashree, 1990). Also, high doses 
(1800–2250 mg/kg/day as manganese (II) sulfate) in mice induce hyperplasia, erosion and 
inflammation in the stomach. Also, number of chromosomal aberrations and micronuclei 
were observed in rat bone marrow (ATSRD, 2000). 
According to WHO (1999) data, other chemical forms of Mn have mutagenic potential, both 
in vitro and in vivo. Thus, more studies are necessary in order to elucidate the probable 
mutagenicity of Mn and its chemical forms and their effects on human health.  
Erbe et al. (2011) evaluated damage to the genetic material of fish (Astyanax sp. B) exposed 
to samples of water from a river and a lake located near a hospital waste landfill. Among 
other parameters, aluminum and manganese were above acceptable levels that have been 
established in environmental legislation. The comet assay detected significant damage to 
genetic material in fish that were acutely exposed in the laboratory to these water samples. 
Bomhorst et al (2010) evaluated the cytotoxicity and genotoxicity potencial of MnCl2, as well 
as its impact on the DNA damage response in human cells (HeLa S3) in culture. Whereas up 
to 10 µM MnCl2 showed no induction of DNA strand breaks after 24 h incubation, 
manganese strongly inhibited H2O2-stimulated poly(ADP-ribosyl)ation at low, completely 
non-cytotoxic, for certain human exposure, relevant concentrations starting at 1 µM. These 
results indicate that manganese, under conditions of either overload due to high exposure or 
disturbed homeostasis can disturb the cellular response to DNA strand breaks, which has 
been shown before to result in neurological diseases. 
Our research group also conducted an in vitro study on the genotoxic, clastogenic and 
cytotoxic potential of MnCl2-4H2O (one of the most common forms of Mn) in different 
phases of the cell cycle, using short-term cultures of human lymphocytes. These effects were 
determined by the mitotic index (MI), chromosomal aberrations (CAs) and DNA damage 
index as detected by the comet assay. MnCl2-4H2O displayed a strong cytotoxicity in all 
phases of the cell cycle. Genotoxicity was observed at  G2 phase of the cell cycle and also in 
the comet assay, what may be related to the lack of time for the cellular repair system to act. 
The absence of CAs in the other phases of the cell cycle suggests that Mn-mediated damage 
may be repaired in vitro (Lima et al., 2008). 
6. Conclusion 
Metal are essential for humans and for all forms of life. Even though metals are necessary in 
biological systems, they are usually required only in trace amounts. As regard to the brain, 
metals are essential for neuronal activities. However, if not correctly regulated, redox-active 
can react with molecular oxygen to generate ROS thus causing brain tissue damage. 
In this chapter, the authors compile several studies that allow to propose that environmental 
metal exposure are a risk factor for neurodegenerative process. A large quantity of toxic 
material is released in the ambient as a consequence of industrial production. High-term 
exposure to certain metals like manganese (Mn), iron (Fe), aluminum (Al) and many others, 
alone or in combination, can lead to neuronal losts and increase Alzheimer’s disease (AD).  
In the cellular neurotoxicity, the Al seems to be the most efficient in promoting Aβ 
aggregation leading to a specific form of Aβ oligomerization that has marked neurotoxic 
effects. Iron has been found to be accumulated in the substantia nigra and is more related 
with neurodegenerative disorders, such as Alzheimer’s (AD) and Huntington’s (HD) 
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diseases and its severity on cognitive impairment aspect (parietal cortex). As for Mn its 
toxicity has been associated with dopamine metabolism leading to neuropsychiatric 
symptoms that resemble idiopathic Parkinson’s disease. 
Our research group published studies on the genotoxic, clastogenic and cytotoxic effects of 
Al, MN and Fe in different phases of the cell cycle using in vitro temporary cultures of 
human lymphocytes. The study indicated that these metals induce DNA damage and is 
cytotoxic during all phases of the cell cycle. Genotoxic studies have shown that exposure to 
some metals cause adverse effects to humans and may be implicated in the pathogenesis of 
some types of neurodegenerative diseases as the AD.  
Although is not completely clear the relationship between some metals and 
neurodegenerative disorders, this chapter suggest that Al, Mn and Fe metals can accelerates 
neuronal death and increase the risk of its development.  
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